companydata.dkcompanydata.dk

Cirqle Biomedical Contraception ApS: Financial statements 2022

CVR: 39865769

Source: annual report 2022, Danish Business Authority

01/01/2022 – 31/12/2022

Cirqle Biomedical Contraception ApS (CVR 39865769) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 62,142,237 and a net result of DKK 47,682,044 compared with DKK -7,208,194 the year before. Equity in the 2022 report amounted to DKK 50,351,201. The solvency ratio was 71.7%. The company had 5 employees in the financial year.

Gross Profit
DKK 62,142,237
Profit/Loss
DKK 47,682,044
Equity
DKK 50,351,201
Total Assets
DKK 70,218,931
Employees
5

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2022-62.1 mio.47.7 mio.50.4 mio.5
2021--5.8 mio.-7.2 mio.-4.4 mio.5
2020--4.1 mio.-5.6 mio.2.8 mio.5

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on Cirqle Biomedical Contraception ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

Registered as owner of Cirqle Biomedical Contraception ApSSep 21, 2022

As of September 21, 2022, is registered as an owner of Cirqle Biomedical Contraception ApS with an ownership share of 5%.

Cirqle Biomedical Contraception ApS: The 2021 annual report is outApr 28, 2022

Cirqle Biomedical Contraception ApS has published its annual report for 2021. Gross profit came to DKK -5,768,965, and the net result was DKK -7,208,194.

About Cirqle Biomedical Contraception ApS

Cirqle Biomedical Contraception ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2018. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Cirqle Biomedical Contraception IVS and Circle Biomedical Contraception IVS. The management consists of Frederik Petursson Madsen and Thomas Crouzier. The board consists of Jesper Boysen (chair), Frederik Petursson Madsen and Thomas Crouzier. The company is owned by Cirqle Biomedical Holding ApS and RH CAPITAL FUND II, LP. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK -2,426,548 and a net result of DKK -6,409,656 compared with DKK 43,425,442 the year before. Equity in the 2025 report amounted to DKK 29,520,931.

Source: annual report 2025, Danish Business Authority

Other financial years